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Three different carbohydrate prosthetic groups associated tothree chymotryptic peptides, QI, Q2 and Q3, were isolated from the reduced and 
carboxymethylated human protein HC. The first oligosaoeharide forms an O-glycosidic l nkage with a threonine r sidue at position 5 in the poly- 
peptide chain of protein HC. The second and third carbohydrate prosthetic groups form N-linkages with asparaglne r sidues at positions 17 and 
96. Oligosaccharides present inQI contain 1residue of NANA, 2 of GalNAc and 1 of Gal corresponding to the following structure: -O-GalNAc- 
GalNAc-GaI-NANA. Q2 contains 3NANA, 9 GlcNAc, 2 Gal and 3 Man, and Q3 contains 2 NANA, 5 GIcNAc, 1 Gal and 2 Man. The sugar 
compositions of Q2 and Q3 oligosaccharides arecompatible with that of the complex kind, The amount of oligosaccharides present inQI, Q2 
and Q3 corresponded r spectively to 3.0%, 12.2% and 7.3% of the weight of protein HC. No difference was found between the carbohydrate composi- 
tion of urinary and plasma protein HC. 
Protein HC; ~q-Microglobulin; Glycoprotein; Carbohydrate 
1. INTRODUCTION 
Human protein HC (al-microglobulin) is a glycopro- 
tein widely distributed in body fluids as free monomer 
and as a complex with IgA [1-3]. The free form consists 
of a polypeptide chain of 183 amino acids [4-6] which 
carries carbohydrates and retinol [7] as well as several 
unidentified yellow-brown fluorescent chromophoric 
groups [1-9]. In the HC-IgA complex, which has an- 
tibody activity [10] and lacks the chromophores [9], 
protein HC and IgA are linked by a reduction- 
insensitive linkage of unknown nature [3]. 
Protein HC has been included in the lipocalin super- 
family [11] which is comprised of a diverse group of 
distantly related animal proteins (retinol binding pro- 
tein, ~-lactoglobulin, etc.), which transport small 
lipophilic biomolecules (retinol, odorants, steroids). 
This superfamily presents amino acid sequence 
homologies, being the human complement component 
C8-r the lipocalin member which displays the highest 
degree of homology with protein HC [12]. More recent- 
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ly, a mRNA has been isolated from human liver, which 
codes for the 30 kDa fragment HI-30 (a serine protease 
inhibitor) and for protein HC [6]. The reason why these 
two apparently unrelated proteins are expressed 
together, separated only by two arginine residues and 
processed into two separated functional molecules, is 
still unknown. Although protein HC acts in vitro as an 
inhibitor of neutrophil chemotaxis and has immuno- 
regulatory properties [13], the biological function of 
this protein is still unknown. In this paper we study the 
carbohydrate prosthetic groups of human protein HC. 
Our data demonstrate the location of the oligosac- 
charide chain, the nature of their linkages to the 
polypeptide chains of protein HC and their monosac- 
charide compositions. 
2. MATERIALS AND METHODS 
2.1. Isolation 
Protein HC was isolated from plasma or from a pool of urine of 
different individuals as earlier described [I]. 
2.2. Reduction and carboxymethylation 
Native protein HC (10 mg/ml) in 1 M Tris-HCl buffer, pH 8.5, 
containing 2 mM EDTA and 6 M guanidinium hydrochloride, was 
reduced with 0.06 M DTT for 120 min at 37°C. Alkylation was 
achieved by addition of iodoacetic a id to a final concentration f 89 
raM. After incubation for 15 min at room temperature, in the absence 
of light, the excess of reagents was removed bisize-exclusion HPLC 
on a TSK-G 3000 SWG column (21.5 mmx 30 cm), by isocratic elu- 
tion with 0.1 M ammonium acetate buffer, pH 6.9. 
2.3. Chymotryptic digestion 
4.5 mg of reduced and carboxymethylated protein HC were 
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digested with a-chymotrypsin at an enzyme/substrate ratio of 1:100 
(w/w) in 0.2 M N-methylmorpholine ac tate buffer, pH 8.2, for 4 h 
at 37°C. 
2.4. Peptide fractionation 
Chymotryptic peptides were fractionated by RP-HPLC on a C-18 
Nova-Pak column (3.9 mm × 15 cm) equilibrated with 0.1% (v/v) 
trifluoroacetic acid. The elution of peptides was performed with a 
linear gradient of acetonitrile from 0% to 32%, containing 0.1% 
(v/v) trifluoroacetic acid, at a flow rate of 0.5 ml/min at room 
temperature. 
2.5. Amino acid analysis 
Peptides were hydrolysed with 0.1 ml of 5.7 M HCI containing 
0.05% (v/v) 2-mercaptoethanol at 110°C for 20 h and the amino acid 
analyses performed using a Beckman 121 MB amino acid analyzer. 
2.6. Carbohydrate analysis 
Aliquots of protein HC obtained from both urine and plasma s 
well as aliquots of the three chymotryptic peptides QI-3 were 
hydrolysed with 8 M HCI at 96°C for 3 h. The hydrolysates were 
dansylated and the obtained erivatives were purified on SepPac 
C-18. Glucosamine and galactosamine derivatives were then 
separated by means of RP-HPLC with fluorophotometric detection 
[4]. Another aliquot was hydrolysed in25 mM HCI (2 h at 80°C) for 
subsequent analysis of sialic acids. These hydrolysates were per-O- 
benzoylated, and following purification on SepPac C-18, the obtain- 
ed derivatives of N-acetyl- and N-glycolyl-neuraminic acids were 
separated by means of RP-HPLC with UV detection [15]. A third ali- 
quot was lyophylised and taken for methanolysis (0.5 M HC1 in dry 
methanol, 100°C for 30 h). The obtained neutral monosaccharides 
were analysed by means of RP-HPLC with refractive index detection 
[16]. The obtained peaks were quantitated by comparing with 
monosaccharides that were methylated under the same methanolytic 
conditions. The total content of neutral sugars was determined col- 
orimetrically, using an automated version of the anthron procedure 
[17], and with 1:1 mixtures of Man and Gal as standards. The 
possibility of uronic acids being present in the preparations was also 
considered, taking a fourth aliquot for this analysis [18]. 
3. RESULTS AND DISCUSSION 
The complete sugar composit ion of the ur inary pro- 
tein HC is shown in Table I. A total of 16 residues of 
GlcNAc, 2 of GalNAc, 5 of Gal, 6 of Man and 6 of 
NANA corresponding to the relative number  of 
monosaccharides of 8:1:2.5:3:3, respectively, were 
found.  N-Glycolylneuraminic acid derivatives were not 
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Fig. 1. Fractionation by RP-HPLC of chemotryptic peptides from 
reduced and carboxymethylated protein HC. The digest, 30 nmol in 
220 #1 of 0.1% trifluoroacetic a id, was injected into a C- 18 Nova Pak 
column and eluted with a gradient of acetonitrile as indicated in sec- 
tion 2. The flow-rate was 0.5 ml/min and 0.5 ml fractions were col- 
lected. The eluent was pooled as indicated by bars. QI, Q2 and Q3 in- 
dicate the peaks containing lycopeptides. 
detected, nor was any uronic acid. The sugar composi- 
t ion of plasma protein HC was also nearly identical to 
that of ur inary protein HC (Table I), which is in agree- 
ment  with the partial sugar composit ion previously 
reported for both ur inary and plasma protein HC [3]. 
In order to determine the precise number  of car- 
bohydrate prosthetic groups and their location in the 
polypeptide chain of protein HC, the carboxy- 
methylated protein was digested with chymotrypsin and 
fractionated by RP-HPLC.  The chromatogram ob- 
tained is shown in Fig. 1. The amino acid composit ion 
of all chymotryptic peptides revealed that only three of 
them, denominated Q1, Q2 and Q3, contained amino 
sugars and allowed their location in the polypeptide 
chain of protein HC (Table II). Q1 and Q2 were located 
in the N-terminal region, between residues 1-16 and 
17-22, respectively, while Q3 was located in the middle 
part of the molecule between residues 96 and 102 (Fig. 
2). 
The fact that in the process of sequential degradation 
of these peptides the corresponding ani l inothiazol inone 
derivatives of residues Thr in Q1, Asn in Q2 and Q3 
Table I 
Carbohydrate composition of carbohydrate-containing chymotryptic peptides of protein HC and urinary and plasma protein HC 
Chymotryptic peptides Protein HC 
Q 1 Q2 Q3 Q 1 + Q2 + Q3 Urine Plasma 
NANA 1.5a(1) b 3.1 (3) 2.0 (2) 6.6 (6) 6.1 (6) ND 
GIcNAc 0.2 (0) 9.4 (9) 5.3 (5) 14.9 (14) 15.7 (16) 14.2 (14) 
GalNAc 2.5 (2) 0.2 (0) 0.2 (0) 2.9 (2) 2.0 (2) 1.7 (2) 
Gal 1.0 (1) 2.0 (2) 1,2 (1) 4.3 (4) 5.3 (5) 5.4 (5) 
Man 0.0 (0) 3.4 (3) 2.3 (2) 5.7 (5) 5.8 (6) 4.9 (5) 
Fuc 0.0 (0) 0.2 (0) 0.1 (0) 0.3 (0) 0.2 0.6 
M.W. c 931 3819 2265 7015 7819 ND 
a Residues per mole of peptide 
b The theoretical number of monosaccharides is given within 
c Molecular weights are calculated on the basis of theoretical 
ND = not determined 
parentheses 
monosaccharide number indicated within parentheses 
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Table II 
Amino acid composition of carbohydrate containing chymotryptic 
peptides from the reduced and carboxymethylated protein HC 
Q1 Q2 Q3 
Asp 2.7a(3) b
Thr 1.3 (1) 
Ser 
Glu 3.0 (3) 
Pro 3.8 (4) 
Gly 1.0 (1) 
Val 2.0 (2) 
Met 0.5 (1) 
Ile 1.1 (1) 2.1 (2) 1.2 (1) 
Tyr 0.9 (l) 0.8 (1) 
Phe 0.9 (1) 
Arg 1.0 (1) 
Yield (nmol) 20.8 24.1 22,2 
(1-16)* (17-22)* (96-102)* 
0.9 (1) 1.0 (1) 
1.0 (1) 
0.9 (1) 0.9 (1) 
1.0 (1) 
a Residues per mole of peptide 
b The number of residues as calculated from the known sequence (3,4) 
is given within parentheses 
* Location of peptides in the polypeptide chain 
could not be found in the chlorobutane extract, remain- 
ing in the spinning cup, could be due to the presence of 
carbohydrate prosthetic groups attached to these amino 
acid derivatives. These results suggest he presence of 
sugar prosthetic groups linked to the above residues of 
Thr and Asn, respectively, which correspond to posi- 
tions 5, 17 and 96 in the polypeptide chain of protein 
HC (Fig. 2). 
The sugar composition of the three chymotryptic 
peptides hows that Q1 contains 1 NANA, 2 GalNAc 
and 1 Gal, Q2 contains 3 NANA, 9 GIcNAc, 2 Gal and 
3 Man and Q3 contains 2NANA, 5 GIcNAc, 1 Gal and 
2 Man (Table I). The total number of monosaccharides 
calculated from these three peptides: 6 NANA, 14 
GlcNac, 2 GalNAc, 4 Gal and 5 Man is in agreement 
with the value obtained for the intact molecule (Table 
I). 
The presence of GalNAc in Q1 corroborates the ex- 
istence of an O-glycosidic linkage between this sugar 
with the only residue of Thr in peptide Q1, while the 
presence of GIcNAc in Q2 and Q3 ratifies the existence 
of an N-glycosidic linkage between this sugar and also 
the only residue of Asn present in peptides Q2 and Q3. 
The sugar composition of Q2 and Q3 is typical of that 
of complex kind N-glycosidic linked oligosaccharides. 
The sequence Asn-X-Thr/Ser, necessary for the attach- 
ment of N-linked oligosaccharides, i  present in both 
glycopeptides. 
The results obtained in this paper, which display the 
presence in protein HC of one O-glycosidic linkage and 
two N-glycosidic linkages, differ from those previously 
reported for the oq-microglobulin, which indicated the 
presence of three identical N-glycosidic linked car- 
bohydrate chains without specifying their location in 
the polypeptide chain [19]. The main reason for this 
discrepancy may reside in the fact that structural studies 
on the carbohydrate portion of oq-microglobulin were 
performed with the complete molecule rather than with 
individual carbohydrate containing peptides as in the 
present work. The present analysis of the carbohydrate 
content in protein HC demonstrates some significant 
differences between the three oligosaccharide contain- 
ing peptides, Firstly, the Q 1 peptide carries a quite small 
oligosaccharide with NANA, GalNAc and Gal in the 
relative molar proportions 1:2:1. This composition in- 
dicates an unbranched chain with NANA in the 
nonreducing end and a GalNAc-GalNAc disaccharide 
binding to the threonine, with the tentative sequence: 
-O-GalNAc-GalNAc-Gal-NANA, similar to what has 
been shown in epithelial glycoproteins [20]. This Q1 
carbohydrate moiety is O-linked to the protein 
backbone, and was therefore probably not detected 
when fluoroacetolysis was used in the previous 
ax-microglobulin study. The Q2 and Q3 peptide both 
have oligosaccharides with GIcNAc and Man as 
dominating constituents. The relative proportions of 
monosaccharides in these N-linked oligosaccharides are 
(O) -Ga lNAc  .... (N) -G IcNAc  .... 
1 I I 
GPVPTPPDNIQVQENFNISR IYGKWYNLAIGSTGPWLKKIMDR MTVSTLVLGEGATEAEISM 
Q1 Q2 
I I I 
(N) -G IcNAc  .... 
90 I 
TSTRWRKGVGEETSGAYEKTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSR HH 
Q3 
I I 
183 
GPT ITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSIFTMADRGECVPGEQEPEP IL IPR  
Fig. 2. Location of the three carbohydrate-containing chymotryptic peptides Q1, Q2 and Q3 in the polypeptide chain of protein HC. The first sugar 
of each oligosaccharide chain is indicated over the amino acid to which it is linked. 
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similar, but the amounts o f  sugars as well as the propor- 
tions o f  GlcNAc and NANA are considerably higher in 
Q2. These oligosaccharides may well be branched 
through a Man triplet, and with a NANA terminating 
each antenna. The higher contents of  GlcNAc and 
NANA both indicate that the much larger Q2 oligosac- 
charide has three or more antennas, while the smaller 
Q3 group only carries two. The complete accurate se- 
quential composit ion o f  these three oligosaccharides re- 
mains, however, to be elucidated. 
The molecular masses o f  the oligosaccharides present 
in Q1, Q2 and Q3, as well as the total carbohydrate in
protein HC, calculated on the basis of  a theoretical 
number o f  monosaccharides, obtained from their car- 
bohydrate compositions, were: 931, 3819, 2265 and 
7015, respectively (Table I). Thus the whole car- 
bohydrate content represents 23% of  the molecular 
mass of  protein HC. Oligosaccharides in Q1, Q2 and 
Q3 correspond to 3.00-/0, 12.2°70 and 7.30/0 of  the 
molecular mass of  protein HC including its 
chromophores.  
As in other glycoproteins, the oligosaccharides of  
protein HC can play an active role in its 
physicochemical properties, turnover regulations, in- 
teraction with macromolecules and cellular surfaces. 
The possibility that in the case of  protein HC the car- 
bohydrates could be also involved in the linkages be- 
tween the polypeptide chain and the associated 
chromophores is intriguint and remains to be in- 
vestigated. 
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